Category: Federal Forum Posters
Purpose: It is projected there will be 8 million Americans with heart failure (HF) by the year 2030. In the United States, HF costs exceeded $30 billion in 2012 with direct medical costs totaling 68% of the expenses. HF is an ambulatory care sensitive condition (ACSC) and readmission prevention is high priority for healthcare systems. Including pharmacists in patient care teams improves patient outcomes. Medication optimization is crucial in improving morbidity and mortality, therefore reducing hospitalizations in high risk HF patients. The primary objective of this project is to develop and implement a pharmacist-led HF clinic that focuses on optimizing medications.
Methods: This quality improvement project will be approved by the Pharmacy and Therapeutics Committee and does not require IRB approval prior to implementation. This project will use a Veterans Affairs (VA) database to identify patients with a HF diagnosis who are at high risk for hospital readmission. A chart review will be conducted and all appropriate patients will have a consult entered for clinic enrollment. Once enrolled, the intervention window will begin and the patient will be followed in clinic for 4 months with a primary focus on providing guideline-directed medical therapy (GDMT). Additionally, any patient with a HF hospitalization not already enrolled in clinic will be enrolled within 14 days of hospital discharge. Patients enrolled after hospital discharge must be seen in clinic for a minimum of 2 appointments so that the clinic can provide GDMT. After the intervention period, another chart review will be conducted to assess the clinic’s ability to provide GDMT to veterans. Results will be assessed using descriptive and/or inferential statistics.
Results: Not applicable
Conclusion: Not applicable
Amy Lynn– Pharmacy Resident, Sheridan VA Healthcare System, Sheridan, WY